DNA methylation at enhancers identifies distinct breast cancer lineages
2017 · Nature Communications · 154 citations
https://doi.org/10.1038/s41467-017-00510-x
X
Xavier Tekpli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
2.1K
Citations
27
h-index
45
i10-index
Xavier Tekpli is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Epigenetics and DNA Methylation & Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers. The author has an h-index of 27, co-authored 102 publications.
ORCID: 0000-0003-4042-8290Papers by this author
worksSpatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer
2020 · Scientific Reports · 152 citations
https://doi.org/10.1038/s41598-020-75708-z
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
2021 · Genome Medicine · 55 citations
https://doi.org/10.1186/s13073-021-00880-4
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of <scp>ER</scp>‐positive breast cancer
2020 · International Journal of Cancer · 18 citations
https://doi.org/10.1002/ijc.33108
Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
2020 · Breast Cancer Research and Treatment · 11 citations
https://doi.org/10.1007/s10549-020-05763-7
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes
2024 · Heliyon · 5 citations
https://doi.org/10.1016/j.heliyon.2024.e32529
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat